semaglutide aspiration case report anesthesia 2023 Glucagon-like peptide-1 receptor agonists and impaired gastric emptying: a pharmacovigilance analysis of the US Food and Drug Administration adverse event reporting system GLP-1 Agonists and the Risk

Reference URLs: This content is provided for informational and laboratory research purposes only

Employers and plan sponsors should be watching this closely because it could reshape how we think about formulary decisions and prior authorization criteria for this drug class

Health Canada noted in its news release that many generic medications in Canada are 45% to 90% cheaper than brand-name versions [Source: canada.ca/en/health-canada/news/2026/04/canada-becomes-the-first-g7-country-to-approve-a-generic-version-of-semaglutide.html]

To view or add a comment, sign in Generic Semaglutide Enters the Market But With Caution The growing demand for GLP-1 weight-loss and diabetes drugs such as Wegovy, Ozempic, and Mounjaro has triggered a significant shift in the pharmaceutical market

Some Cigna plans cover weight loss pills like Adipex-P ( phentermine ), Contrave (naltrexone/bupropion), Qsymia (phentermine/topiramate), and Xenical (orlistat)